Entyvio®

Active substance Vedolizumab
Holder Takeda
Status Closed
Indication Patients with ulcerative colitis that have failed at least 2 previous anti-TNF or for whom anti-TNF are contra-indicated
Public documents Approbation
Information for the patient
Informed consent
Last update 24/03/2015
Last updated on 13/02/2024